| | |
| 0790 |
1:45 PM | Targeting of Human Squamous Carcinomas by SPA470-Doxorubicin
C. HEBERT, K. NORRIS, and J.J. SAUK, University of Maryland, Baltimore, USA |
| 0791 |
| WITHDRAWN
| | 0792 |
2:15 PM | The Use of Oral Scrapings in the Assessment of Genetic Damage in Oral Lesions
J.M. RISK, D.N. SUTTON, S.N. ROGERS, E.A. FIELD, and J.K. FIELD, The University of Liverpool, United Kingdom |
| 0793 |
2:30 PM | Molecular Grading of the Invasive Tumor Front Predicts Clinical Aggressiveness of Oral Cancer
J. PIFFKO1, A. BANKFALVI1, M. KELKER1, A. VEGH2, and U. JOOS1, 1 University of Münster, Germany, 2 Heim Pál Sick-Children Hospital, Budapest, Hungary |
| 0794 |
2:45 PM | Ligation of CD40 with Soluble CD40L Inhibits Proliferation of Oral Keratinocytes in vitro
M. VILLARROEL DORREGO, P.M. SPEIGHT, and A.W. BARRETT, Eastman Dental Institute for Oral Health Care Sciences, London, United Kingdom |
| 0795 |
| WITHDRAWN
| | 0796 |
3:15 PM | Expression of CD97 and EMR2 in Oral Squamous Cell Carcinomas
T. MUSTAFA, A.W. ECKERT, T. KLONISCH, A. KEHLEN, J. SCHUBERT, H. DRALLE, H. SEYFERT, and C. HOANG-VU, Martin-Luther-University Halle-Wittenberg, Germany |
| 0797 |
3:30 PM | Oral Squamous Cell Carcinoma-derived TGF-b Promotes Myofibroblast Differentiation and Scatter-factor-dependent Invasion
M.P. LEWIS1, K.A. LYGOE1, M.L. NYSTROM2, P.M. SPEIGHT1, and G.J. THOMAS1, 1 Eastman Dental Institute for Oral Health Care Sciences, London, United Kingdom, 2 Richard Dimbleby/CRUK Laboratories, London |
|